ArticleJournal of neurology, neurosurgery, and psychiatry2021

CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.

Giovanna Capodivento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.